What they say: Introduction:
A recent study from the Department of Genetics, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging Harvard Medical School, Boston,USA; and Department of Pharmacology, School of Medicine, The University of New South Wales, Australia shows that Sirtuin-2 induces the checkpoint kinase BubR1 to increase lifespan. This study was published, in the 1 July 2014 issue of the journal “EMBO”, by Prof Sinclair, North BJ, and others.
What we say:
On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Lifespan extension therapy: D-3-Hydroxy Butyrate (3HB) increases life span via up-regulation of its target gene BubR1
What is known?
D-3-Hydroxy Butyrate (3HB) has been shown to extend murine lifespan. However, the exact mechanism of action is far from clear.
From research findings to Therapeutic Opportunity:
This study suggests, for the first time, that D-3-Hydroxy Butyrate (3HB), by increasing the expression of its target gene, it may: (a) increase the expression of BuBR1; (b) decrease the expression of p70 S6 Kinase; and (c) regulate the expression of a number of longevity-promoting molecules (Fig. 1).
[easy_payment currency=”USD”]
Figure 1. A therapeutic mix encompassing D-3-Hydroxy Butyrate (3HB) may extend mammalian life span via up regulation of BuBR1 and down regulation of p70 S6 Kinase
Figure 2. The chemical structure of D-3-Hydroxy Butyrate (3HB)
Thereby, it may: (1) increase insulin sensitivity; (2) attenuate cognitive impairment; (3) delay diseases of aging; (4) slow down cardiac aging; (5) promote resistance to bone, immune and motor dysfunction; (6) promote tissue rejuvenation; and (7) prolong median life span. Thus, pharmacological formulations encompassing “D-3-Hydroxy Butyrate (3HB) or its analogues, either alone or in combination with other drugs“ may be used to extend the lifespan of an individual (fig. 2).
Details on the research findings:
Idea Proposed/Formulated (with experimental evidence) by:
Dr L Boominathan Ph.D.
Amount: $500#
Undisclosed mechanistic information: How a pharmaceutical mix encompassing D-3-Hydroxy Butyrate (3HB) increases the expression of BubR1 and extends mammalian life-span
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
# Research cooperation
References:
Web: http://genomediscovery.org or http://newbioideas.com
Citation: Boominathan, L., Lifespan extension therapy: D-3-Hydroxy Butyrate (3HB) increases life span via up-regulation of its target gene BubR1, 4/February/2018, 11.41 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Courtesy: When you cite drop us a line at admin@genomediscovery.org